SCHEMBL10187272

SCHEMBL10187272

Cc1ccc(BO)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.48
▸ TP53 P04637 3/20 0.48
▸ TRPA1 O75762 1/20 0.39
▸ CYP1A2 P05177 3/20 0.38
▸ CYP2A6 P11509 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ RAPGEF4 Q8WZA2 2/20 0.35
▸ ALOX15 P16050 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14140533 0.81 NFE2L2 (0.36) TDP1TP53TRPA1CYP1A2CYP2A6
SCHEMBL2409646 0.80 TDP1 (0.42) TDP1TP53TRPA1CYP1A2CYP2A6
SCHEMBL13366299 0.77 TDP1 (0.44) TDP1TP53TRPA1CYP1A2CYP2A6
SCHEMBL10175432 0.76 GABRA1 (0.38) TDP1TP53TRPA1CYP1A2CYP2A6
SCHEMBL17366279 0.76 IDO1 (0.30) —
SCHEMBL25559695 0.76 TRPA1 (0.36) TDP1TP53TRPA1CYP1A2CYP2A6
SCHEMBL20643790 0.69 TP53 (0.38) TDP1TP53TRPA1ALDH1A1MEN1
SCHEMBL470363 0.69 — —
Methyl Alcohol SCHEMBL11116510 0.67 TDP1 (0.57) TDP1TP53TRPA1CYP1A2CYP2A6
Hydrogen Peroxide SCHEMBL4451014 0.67 TDP1 (0.57) TDP1TP53TRPA1CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 — — EP disclosed
WO-2012001107-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-05 — — WO disclosed
Send feedback